the following describes complex includes, as a first part, a part derived from an antibody that specifically binds to a target antigen, and a second part, a peptide derived from a virus linked to a protein complex of mhc class i.the following describes complex directs the circulating virus specific cytotoxic t cell (t cell) or existing memory effector cells (t) of a person to cells expressing the target antigen and antibodies derived from a part of the covalent complex binds. specifically,a primer of cells with mhc class i complexes mimicking an acute viral infection.therefore, one aspect described herein is a complex, characterised in that it comprises a fusion polypeptide comprising, in accordance with the terminal end for c, b2 microglobulin (i) and (ii) the extracellular areas a1, a2, and a3 of a molecule, mhc class (i) at a frequency of less than 1%, (i) a peptide derived from a virus.(ii) a b2 microglobulin, and (iii) the extracellular areas a1, a2, and a3 of an mhc class i molecule with a frequency of 1% or more, and the two polypeptide chains, which are linked by one or more disulfide bonds.the first polypeptide chain linked by a disulfide, the terminal end to (c), (i) the variable domain of an immunoglobulin light chain and heavy, (ii) the light or heavy chain constant of an immunoglobulin, and (iii) a polypeptide is and the key region of a heavy chain of antibody.and the second polypeptide chain linked by a disulphide is a polypeptide corresponding to the hinge region of a heavy chain antibodies, fusion polypeptide is covalently linked to the terminal end (or at the terminal end of one of the chains. ypeptidiques linked through a disulfide.is covalently linked to the terminal end of a field variable is the variable domain of antibody light and heavy chain complementary to that in the first polypeptide chain linked by a disulfide.Le complexe ci-décrit comprend, à titre de première partie, une partie dérivée d'un anticorps qui se lie spécifiquement à un anti
